跳至主要内容
临床试验/NCT02412397
NCT02412397Unknown不适用

DePuy Global Unite Shoulder System

Rothman Institute Orthopaedics0 个研究点目标入组 80 人开始时间: 2015年4月9日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
主要终点
Implant Survivorship

研究概览

简要总结

To collect medium to long-term survivorship implant outcomes on the DePuy Global Unite Shoulder System

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient greater than 18 years of age and skeletally mature
  • Patient qualifies for primary or revision total or reverse shoulder arthroplasty based on diagnosis of investigator of osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, un-united humeral head fractures, irreducible 3- and 4- part proximal humeral fracture, avascular necrosis, or gross rotator cuff deficiency.
  • Patient is willing and able to provide written informed consent and to complete scheduled follow up visits/evaluations/questionnaires

排除标准

  • Patient has one of the following compromise the affected limb; a significant injury to the upper brachial plexus, paralysis of the axillary nerve, or a neuromuscular disease compromising the affected limb
  • Patient has a known or suspected infection
  • Patient is known to be pregnant
  • Patient has a sensitivity or allergic reaction to one or more of the implanted materials
  • Patient is unwilling or unable to provide consent or comply with follow up visits

结局指标

主要结局

Implant Survivorship

时间窗: 10 years post-operative

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验